Autoimmunity in obstetrics and autoimmune diseases in pregnancy

被引:24
作者
De Carolis, Sara [1 ,4 ]
Moresi, Sascia [1 ]
Rizzo, Francesca [1 ]
Monteleone, Giuseppina [1 ]
Tabacco, Sara [2 ]
Salvi, Silvia [1 ]
Garufi, Cristina [3 ]
Lanzone, Antonio [1 ,4 ]
机构
[1] Fdn Policlin Univ A Gemelli IRCCS, UOC Patol Ostetr, Dipartimento Sci Salute Donna Bambino & Sanita Pu, Rome, Italy
[2] Sapienza Univ Roma, Umberto I Hosp, Dept Gynecol & Obstet Sci & Urol Sci, Rome, Italy
[3] Sapienza Univ Roma, Umberto I Hosp, Lupus Clin, Dipartimento Med Intema & Special Med, Rome, Italy
[4] Univ Cattolica Sacro Cuore, Ist Clin Ostetr & Ginecol, Rome, Italy
关键词
APS; SLE; Pregnancy; IUGR; Fetal loss; PRIMARY SJOGRENS-SYNDROME; ANTIPHOSPHOLIPID SYNDROME; HEART-BLOCK; FETAL; WOMEN; OUTCOMES; LUPUS; REPRODUCTION; PREDICTORS; STANDARD;
D O I
10.1016/j.bpobgyn.2019.03.003
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Autoimmune diseases (AIDS) are associated with strong female preponderance and often present before or during the reproductive years; consequently, pregnancy and breastfeeding are topics of major interest for these patients. AIDs show different responses to pregnancy: some ameliorate, while others remain unchanged, and several AIDS aggravate. The response of the AIDS to the hormonal and immunological alterations of pregnancy reflects the different pathophysiology of each disease. Systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS) are associated with multiple autoantibodies, multiorgan involvement, more aggressive therapy, and increased impact on pregnancy outcome. For the management of pregnancy in patients with SLE and/or APS, it is important to individuate the correct risk profile for each woman and timing for treatment. The optimal timing for starting or modulating treatment is at preconception assessment to influence the placentation. In this chapter, we discuss the management of pregnancy in patients with AIDs. (C) 2019 Published by Elsevier Ltd.
引用
收藏
页码:66 / 76
页数:11
相关论文
共 47 条
[11]   Association between false-positive TORCH and antiphospholipid antibodies in healthy pregnant women [J].
De Carolis, S. ;
Tabacco, S. ;
Rizzo, F. ;
Perrone, G. ;
Garufi, C. ;
Botta, A. ;
Salvi, S. ;
Panici, P. Benedetti ;
Lanzone, A. .
LUPUS, 2018, 27 (05) :841-846
[12]   Antiphospholipid syndrome: An update on risk factors for pregnancy outcome [J].
De Carolis, Sara ;
Tabacco, Sara ;
Rizzo, Francesca ;
Giannini, Andrea ;
Botta, Angela ;
Salvi, Silvia ;
Garufi, Cristina ;
Panici, Pierluigi Benedetti ;
Lanzone, Antonio .
AUTOIMMUNITY REVIEWS, 2018, 17 (10) :956-966
[13]   The impact of primary Sjogren's syndrome on pregnancy outcome: Our series and review of the literature [J].
De Carolis, Sara ;
Salvi, Silvia ;
Botta, Angela ;
Garofalo, Serafina ;
Garufi, Cristina ;
Ferrazzani, Sergio ;
De Carolis, Maria Pia .
AUTOIMMUNITY REVIEWS, 2014, 13 (02) :103-107
[14]   Women with rheumatoid arthritis negative for anti-cyclic citrullinated peptide and rheumatoid factor are more likely to improve during pregnancy, whereas in autoantibody-positive women autoantibody levels are not influenced by pregnancy [J].
de Man, Y. A. ;
Bakker-Jonges, L. E. ;
Dufour-van den Goorbergh, C. M. ;
Tillemans, S. P. R. ;
Hooijkaas, H. ;
Hazes, J. M. W. ;
Dolhain, R. J. E. M. .
ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (02) :420-423
[15]   Association of Higher Rheumatoid Arthritis Disease Activity During Pregnancy With Lower Birth Weight Results of a National Prospective Study [J].
de Man, Yael A. ;
Hazes, Johanna M. W. ;
van der Heide, Hugo ;
Willemsen, Sten P. ;
de Groot, Christianne J. M. ;
Steegers, Eric A. P. ;
Dolhain, Radboud J. E. M. .
ARTHRITIS AND RHEUMATISM, 2009, 60 (11) :3196-3206
[16]   Factors associated with adverse pregnancy outcomes in women with antiphospholipid syndrome: A multicenter study [J].
Deguchi, Masashi ;
Yamada, Hideto ;
Sugiura-Ogasawara, Mayumi ;
Morikawa, Mamoru ;
Fujita, Daisuke ;
Miki, Akinori ;
Makino, Shintaro ;
Murashima, Atsuko .
JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2017, 122 :21-27
[17]   BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids [J].
Flint, Julia ;
Panchal, Sonia ;
Hurrell, Alice ;
van de Venne, Maud ;
Gayed, Mary ;
Schreiber, Karen ;
Arthanari, Subha ;
Cunningham, Joel ;
Flanders, Lucy ;
Moore, Louise ;
Crossley, Amy ;
Purushotham, Neetha ;
Desai, Amisha ;
Piper, Madeleine ;
Nisar, Mohamed ;
Khamashta, Munther ;
Williams, David ;
Gordon, Caroline ;
Giles, Ian .
RHEUMATOLOGY, 2016, 55 (09) :1693-1697
[18]   Recurrent spontaneous abortion and intrauterine fetal growth retardation as symptoms of coeliac disease [J].
Gasbarrini, A ;
Torre, ES ;
Trivellini, C ;
De Carolis, S ;
Caruso, A ;
Gasbarrini, G .
LANCET, 2000, 356 (9227) :399-400
[19]   Pregnancy and fetal outcome in women with primary Sjogren's syndrome compared with women in the general population: a nested case-control study [J].
Hussein, Sarwen Z. ;
Jacobsson, Lennart T. H. ;
Lindquist, Pelle G. ;
Theander, Elke .
RHEUMATOLOGY, 2011, 50 (09) :1612-1617
[20]   Congenital Complete Heart Block in Fetal Echocardiography [J].
Singh, Amit Kumar ;
Rajak, Brijmohan ;
Singh, Ruby ;
Mandal, Jitendra .
NEPALESE HEART JOURNAL, 2021, 18 (02) :61-63